Veradigm | MDRX - Operating Profit

Stock Price
4.31
Daily Change
-0.19 -4.22%
Monthly
-6.30%
Yearly
-15.49%
Q1 Forecast
7.75

Veradigm reported $25M in Operating Profit for its fiscal quarter ending in September of 2022.





Operating Profit Change Date
Alcidion AUD 444K 1.55M Jun/2025
Ambu A/S DKK 164M 17M Dec/2025
Amplifon EUR 24.29M 45.59M Sep/2025
Cardinal Health USD 763M 9M Dec/2025
Centene USD -1.23B 1.03B Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Cigna USD 2.75B 240M Sep/2025
Computer Programs Systems USD 1.94M 4.96M Sep/2024
Convatec Group USD 175.7M 101.1M Dec/2024
CVS Health USD 2.11B 836M Dec/2025
Diasorin EUR 56.68M 18.65M Sep/2025
Elevance Health USD 581M 1.18B Dec/2025
General Electric Aerospace USD 1.77B 536M Dec/2025
Gulf Medical Proj AED 14.87M 16.62M Jun/2025
Humana USD -808M 1.21B Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratory Of America USD 382M 15.3M Dec/2025
Maximus USD 146.21M 23.35M Dec/2025
McKesson USD 1.66B 159M Dec/2025
Med Life RON 40.09M 1.45M Sep/2025
Molina Healthcare USD -153M 293M Dec/2025
Omnicell USD 1.18M 9.81M Dec/2025
Oriola-kd EUR 6.6M 8M Sep/2025
Owens Minor USD 56.75M 56.63M Jun/2025
Quest Diagnostics USD 386M 0 Dec/2025
Rede D'or Sao Luiz BRL 2.73B 475.99M Sep/2025
Siemens Healthineers EUR 677M 214M Dec/2025
Sonova Holding CHF 296.8M 156.9M Dec/2025
Supermax Corporation Bhd MYR -143.15M 38.31M Sep/2025
UnitedHealth USD 3.26B 1.06B Dec/2025
Veeva Systems USD 240.85M 14.32M Sep/2025
Veradigm USD 25M 30.36M Sep/2022
Xerox USD 30M 48M Jun/2025